This not only saves laboratories time, but also improves data quality. The combination of confocal laser scanning microscopy with AI-supported image analysis using lasers opens up the potential to automatically determine quantitative parameters such as tumor thickness or cell invasiveness. For laboratories, this means a reduction in routine pathological tasks and a more objective diagnosis. At the same time, telepathology allows digital scans to be sent to experts worldwide in real time - ideal for complex cases or second opinions without the need for logistics.
Initial pilot projects in urology, neurosurgery and oncology (e.g. breast and bladder cancer) show that ex vivo confocal laser scanning microscopy is also practicable outside of dermatology. The possibility of using fluorescence-labeled antibodies for immunohistochemical markers in the future could further expand diagnostics and provide immunohistochemistry information in real time.